Conditioned medium recovered from fetal rat calvarial cultures contains an autocrine factor termed bonederived growth factor (BDGF); this factor has been purified by acid extraction, gel-permeation chromatography, and two reversed-phase HPLC steps and examined for mitogenicity on normal rat kidney fibroblasts (NRK, clone 49F). HPLCpurified BDGF caused a dose-related increase in cell number, DNA content, and [3H]thymidine incorporation into acidinsoluble material. Since highly purified BDGF appeared less mitogenic than cruder preparations, the latter were tested for additional growth factors, with particular attention to those required for anchorage-independent colony formation in soft agar. BDGF did not displace III-labeled epidermal growth factor (EGF) in a radioligand-receptor assay, indicating the absence of EGF and transforming growth factor a (TGF-a). Without EGF, no BDGF preparation induced NRK cells to form soft agar colonies. However, calvarial conditioned medium contained a factor which, like TGF-., induced large soft-agar colonies in the presence of EGF; this TGF-f-like factor did not copurify with BDGF. Polyclonal antibodies against platelet-derived growth factor did not neutralize the effects of BDGF on NRK cells. BDGF is a potent mitogen for nonskeletal-tissue-derived fibroblasts. Although crude BDGF preparations do contain TGF-P, BDGF is distinct from this factor and others necessary for NRK cell transformation to anchorage-independent growth.
Studies with conditioned medium (CM) obtained from fetal rat calvarial cultures suggested the presence of biologically active molecules that stimulated DNA and protein synthesis in subsequently cultured calvariae (1) . The major bone growth promoter in these preparations, bone-derived growth factor (BDGF), also stimulates cartilage growth in rabbit costal chondrocyte cultures (2) , but the effect of BDGF on nonskeletal tissue has not been reported.
NRK-49F are continuously cultured cells cloned from a normal rat kidney fibroblast (3) ; they exhibit density-dependent growth arrest after reaching confluence in culture but can be stimulated to divide further by fresh serum or mitogenic factors. Some of these factors have been termed transforming growth factors (TGFs; refs. 4 and 5) because they induce alteration from normal cell growth on a culture surface to anchorage-independent colony formation in softagar suspensions (6) . This characteristic has been consistently correlated with tumorigenicity (7) . TGFs have been isolated directly from normal and neoplastic tissues or from their culture medium (6, (8) (9) (10) (11) (12) and have been classified with relation to mouse epidermal growth factor (EGF). Rat TGFa, a polypeptide of Mr 5600, binds to the EGF receptor and shares extensive sequence homology and biological properties with EGF (5); both factors can induce small NRK cell colony formation in soft agar (11) . TGF-p, a polypeptide dimer of Mr 24,000, alone is inactive but in the presence of EGF or TGF-a produces larger soft-agar colonies when assayed on NRK-49F cells (6) . Both TGF-a and TGF-p have at times been isolated from the same tissue sources (11, 13) ; the mechanism of TGF-p action appears related to the enhanced expression of EGF/TGF-a receptors (14) . In addition, EGF-dependent cell transformation requires serum or low levels of some serum factors, including plateletderived growth factor (PDGF; ref. 15 ) and somatomedin (16) . Other TGFs (termed TGF-y) were originally reported as EGF-independent transforming agents, but at present their status is unclear due to the complexity of the interactions between TGF-a, and TGF-,B, and other serum factors in various culture systems (4, (15) (16) (17) (18) .
Rat calvarial BDGF has been purified by gel-permeation chromatography and reversed-phase HPLC (rpHPLC). Preliminary studies in calvariae suggested that more purified BDGF preparations were less mitogenic than material derived from Sephadex chromatography. Therefore, we questioned whether rpHPLC separated interdependent activities and tried to determine whether our preparations shared biological or biochemical properties with TGF-a, TGF-P, or PDGF. The last factor has special significance, since osteosarcoma cells produce material immunologically crossreactive with PDGF (19) . As a result of this work we have begun to describe some ofthe growth-stimulating activities of BDGF for nonskeletal tissue-derived fibroblasts.
MATERIALS AND METHODS
Preparation of BDGF. Calvariae from 21-day rat fetuses were cultured in serum-free BGJb (GIBCO) medium without albumin and phenol red. Culture medium was collected daily for 4 days, pooled, acidified, and dialyzed (Mr cut-off 3500) against 0.05 M acetic acid. The retentate (CM-BDGF) was lyophilized, redissolved in 1.0 M acetic acid, and filtered through Sephadex G-75; the material that was eluted at Mr 6000-45,000 (Sephadex-BDGF) either was pooled, lyophilized, and stored at -700C until testing or was fractionated further by rpHPLC on ,Bondapak C18 (Waters Associates). Sephadex-BDGF was applied to the column in 20% methanol/0.025 M acetic acid and eluted with a methanol gradient in 0.1 M acetic acid. Biologically active material was eluted at 50-60% methanol; the active fractions (C18-BDGF) The radioligand-receptor assay was repeated using A431 membranes, which are enriched for EGF receptor and therefore provide more sensitive substrate (24) . The assay was performed according to directions provided by the manufacturer of the assay kit (Biomedical Technologies, Norwood, MA).
Soft-Agar Transformation Assay. Anchorage-independent growth was assayed by methods developed by Todaro and others (9) (10) (11) . Culture wells (2-cm2) were partially filled with DMEM containing 10% newborn calf serum and 0.6% noble agar (Difco). The underlay was allowed to solidify while a single-cell suspension of NRK-49F cells was prepared. An aliquot of cells was diluted with concentrated stock solutions of agar, medium, and test factor(s) so that the final concentrations were 6 x 104 cells per ml, 0.25% agar, and 10% serum; factor levels are detailed in the text. One hundred microliters of the final suspension was pipetted over the underlay, and the cultures were incubated without further addition for 7-14 days under normal conditions. Transformation was assessed in unfixed and unstained cultures by use of a light microscope. Colonies, counted in 9-24 random 3.1-mm2 microscopic fields from three or four replicate culture wells, were categorized as small (-100 ,um in diameter) or large (-200 um in diameter).
PDGF Assay. Anti-PDGF antibody neutralization experiments were carried out with polyclonal antiserum prepared in rabbits against PDGF and kindly provided by C. 
RESULTS
Cell Replication and DNA Synthesis. EGF was used to establish the mitogenic response of NRK cells. At 1-100 ng/ml, EGF increased cell number in density-dependent growth-arrested cells by 50-100% and DNA content by 60-110%. EGF also increased [3H]thymidine incorporation into acid-insoluble material; this effect was dose-dependent and was maximal (7-to 8-fold increase) at 10-30 ng/ml (Fig.  1) .
CN-BDGF was a potent mitogen for NRK cells. At low concentrations (20-120 ng/ml), it increased cell number 40%, whereas at 800 ng/ml, an increase of 70% was detected. BDGF increased DNA content by 20% at 5-50 ng/ml, and at 500 ng/ml a 50% increase was observed. BDGF also produced a marked increase in [3H]thymidine incorporation into acid-insoluble material. The effect was detected at a concentration as low as 3 ng/ml (15-25% the estimated concentration present in calvarial CM, based on CN-BDGF containing 12-20 ng of protein/ml of CM), was linear up to 30-100 ng/ml, and appeared to saturate at about 1 ,g/ml (Fig. 2) .
EGF/TGF-a Content. Since highly purified BDGF appeared to retain less, or less persistent, mitogenic activity than found in cruder preparations (data not shown), we questioned whether synergistic factors such as those necessary for anchorage-independent growth were separated by rpHPLC. Neither Sephadex-nor ,uBondapak C18-purified BDGF could compete with 125I-labeled EGF for binding to NRK cells by radioligand-receptor assay, even at concentrations that were maximally stimulatory to replication ( *l2I-labeled EGF (30 ng/ml, 158 nCi/ng) was incubated in the absence (n = 4) or presence of EGF (n = 2) or BDGF (n = 3); values are means or means ± SEM. Unconcentrated Sephadex-BDGF contained 1.5 pg of protein/ml, whereas unconcentrated C18-BDGF contained 0.74 pg of protein/ml. tl25I-labeled EGF (159 nCi/ml) was incubated in the absence or presence of EGF or BDGF; values are the means of duplicate determinations, which differed from each other by <10%.
Unconcentrated CM-BDGF contained 25 Mg of protein/ml.
EGF and TGF-P (Biomedical Technologies). TGF-,B alone
did not induce anchorage-independent growth, whereas EGF primarily supported small-colony formation; TGF-p and EGF together induced a 2-fold increase in large-colony formation over EGF alone. Highly purified CN-BDGF up to 500 ng/ml did not induce anchorage-independent growth and did not alter the effect of EGF on colony formation (Table 2) . This indicated that the mitogenic effect of BDGF was not due to a TGF but did not eliminate whether cruder preparations contained TGF-like factors. Sephadex-BDGF by itself did not induce large-or small-colony formation, indicating absence of TGF-a or EGF-independent TGFs, but when it was assayed in the presence of EGF, TGF-,B activity was detected. Soft agar colony inducement with EGF at 2 ng/ml (data not shown) or 20 ng/ml was seen with Sephadex-BDGF concentration as low as 0.25 ,ug protein/ml (17% the estimated calvarial CM level of 1.5 ,g of protein/ml); the effect was maximal at a concentration equal to that in calvarial CM (Table 2 and Fig. 3 ). This activity had an estimated Mr of 24,000 on Sephadex G-75 chromatography and peaked independently of BDGF by this method (Fig. 4) and by ,uBondapak C18 HPLC (data not shown).
PDGF Content. Addition of polyclonal anti-PDGF antibodies to NRK cells inhibited PDGF-stimulated replication but did not reduce the mitogenic effect produced by an intermediate dose of BDGF (Fig. 5 ). Since BDGF was tested at the half-maximally effective concentration, any growth promotion due to contaminating PDGF should have been detected at nonsaturating factor levels. tNumber of large colonies/total number of colonies.
tSignificantly different (P < 0.05) from control (no addition).
DISCUSSION
Interest in growth factor-mediated modulation of cell proliferation and differential gene expression has expanded since the purification of a variety of these molecules from diverse tissue sources (1, 2, 6, (25) (26) (27) (28) (29) (30) (31) (32) . Fetal rat calvariae release autocrine factors (BDGF) in culture and respond to these and to factors from other tissues by specific and characteristic changes in macromolecular synthesis. Some factors enhance total calvarial DNA synthesis in conjunction with either increased or decreased synthesis of bone-cell-specific proteins (33) . Therefore, certain factors may affect undifferentiated or non-bone-specific cells, while others may act on calvarial osteoblasts alone or in addition to other cell types also present. Since the calvariae used for assay are metabolically competent, it is difficult to assess whether the agent being assayed has acted alone or in addition to or in synergy with BDGF that the calvariae generate during the treatment period. For these reasons, and to compare BDGF with factors purified in other laboratories, we have begun to characterize the biological and biochemical effects of BDGF on nonskeletal tissue-derived fibroblasts.
We have found that BDGF stimulated NRK cell replication. Saturating levels of BDGF produced a maximal increase of 70% in cell number and 50% in DNA content.
[3H]Thymidine incorporation into DNA was the most sensitive indicator: BDGF at 3 ng/ml was effective, and maximal concentrations increased labeling 40-fold. The relationship between BDGF and skeletal growth factor (SGF) from human and chick bone is unclear, since SGF does not seem to stimulate fibroblast division (36, 37) , but this discrepancy may be due to different assay protocols. Bone morphogenetic protein from bovine bone does stimulate NRK cell growth but does not increase calvarial collagen synthesis (38).
In conclusion, BDGF stimulates fibroblast replication but has no transforming activity for NRK cells. Although fetal rat calvariae release TGF-f3, this factor is independent of BDGF.
